- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $184.51M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $186.96M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.5M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $65.31M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $61.63M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $340.21M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $341.26M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $191.04M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $186.3M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $435.82M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $487.28M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $95.91M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $98.42M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 89.52M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $4.48M |
| Capex | Q1 2025 · Mar 31, 2024 | $2.74M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $33.38M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $173.54M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $222.53M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.55 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.55 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $14.33M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$7.65M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $78.18M |